Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.

Clinical trial NCT07192068 · RECRUITING

Trial details

NCT number: NCT07192068
Sponsor: UNICANCER
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Sarcoma Head &Amp; Neck Cancer Colorectal Carcinoma Endometrial

Start date: 2025-10-30
Primary completion: 2028-03-13
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.